Authors
Latest:
Endometrial ablation in the office settingBreaking down barriers through patient selection, new devices, and the latest techniques.
Latest:
An update on the presentation, nosology, and causes of postpartum psychosisPostpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
Latest:
SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidyIn this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Latest:
Diagnosis and Management of Gestational DiabetesWhat every OB/GYN needs to know to manage this complication.
Latest:
COVID-19's impact on patient portal utilization and disparitiesA recent study analyzing patient portal use amidst the COVID-19 pandemic unveils changes in sociodemographic trends and disparities, highlighting shifts in user behavior and access challenges.
Latest:
FDA approves dostarlimab for dMMR endometrial cancerThe FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.
Latest:
SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidyIn this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Latest:
Combined hormonal contraceptives merit risk assessment in patients with obesityCombined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity.
Latest:
Uma Mahadevan, MD, highlights new guidelines for managing IBDUma Mahadevan, MD, explains updated international recommendations for inflammatory bowel disease in pregnancy.
Latest:
Niraparib Demonstrates PFS Benefit in Chinese Population With Advanced Ovarian CancerFirst-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.
Latest:
Treatment validation platforms can reduce care variations and promote health equityEmerging technology helps ensure best practices while reducing costs of care.
Latest:
Clues to the origins of ovarian cancerFamily history assessment, genetic screening are key to prevention.
Latest:
Megan Wasson, DO, and Ceylan Colak, MD, share how multidisciplinary collaboration advances endometriosis diagnosis and treatmentMegan Wasson, DO, and Ceylan Colak, MD, highlight how imaging and multidisciplinary care improve endometriosis diagnosis, treatment, and patient outcomes at the 2025 ACOG ACSM.
Latest:
Statin use in midlife womenRisk assessment, lifestyle counseling, adverse effects, and medication management.
Latest:
Helping parents cope with adolescent behaviorA teenager’s day-to-day behavior can vary greatly. Here are some tips for understanding and navigating this challenging time.
Latest:
Uterine anomalies in pregnancyClinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Latest:
Bladder health monthReview bladder disorders and management methods you can discuss with your patients.
Latest:
Addressing burnout before impacting your familyToday is Physician Family Day, the perfect time to reflect and address any potential burnout symptoms and spend quality time re-engaging with your loved ones.
Latest:
Demystifying AVMsRisk assessment and management of brain arteriovenous malformations in pregnancy.
Latest:
Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinomaNew trial results showed statistically significant improvements in overall survival and progression-free survival.
Latest:
COVID-19 delays cancer screenings, deaths expected to rise in next 10 yearsCancer programs seek to remove barriers to screenings.
Latest:
Contraception: Hopes for the FutureKate White, MD, MPH, and Harold Bays, MD, discuss their hopes for the future of contraception options, affordability, and clinical trials evaluating their efficacy.
Latest:
New over-the-counter continuous glucose monitoring systems launchedAbbott's Lingo and Libre Rio CGM devices, designed for general health and Type 2 diabetes management respectively, receive FDA approval, offering advanced metabolic health tracking for US consumers.
Latest:
An update on the presentation, nosology, and causes of postpartum psychosisPostpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
Latest:
Postpartum Depression Resources for Providers and PatientsPanelists discuss how providers can utilize resources like Postpartum Support International for training, certification, and referrals, while building community networks and making warm handoffs to ensure patients receive appropriate care without barriers.
Latest:
Radiofrequency ablation for fibroidsUnderstanding the technology behind a newer uterus-sparing option for the management of uterine fibroids.
Latest:
Sex differences in dermatologic conditionsData has indicated an increased prevalence of atopic dermatitis among female patients compared to male patients.
Latest:
Johanna Finkle, MD, on weight loss management in reproductive-aged patientsIn this interview at the 2025 ACOG ACSM, Johanna Finkle, MD, urged clinicians to tailor weight loss care based on BMI, contraception use, and medication risks using patient-centered counseling.
Latest:
The Management of Chronic Gynecologic Conditions During COVID and BeyondExperts discuss management of women’s health including chronic pelvic pain resulting from endometriosis and heavy menstrual bleeding from uterine fibroids. They also discuss ways to help improve patient-provider communications and overcome the normalization associated with non-malignant gynecological conditions.
Latest:
Choosing the right pillOral contraceptive pills are a popular choice for many; providers should understand the options to guide patients effectively.
